摘要:
The present invention provides a porcine beta-casein gene, a porcine beta-casein gene promoter, an expression vector comprising the same promoter, and a method for the production of a target protein using the same expression vector. The promoter of the present invention facilitates mammary gland-specific expression of the target protein and therefore can be useful for high-concentration production of beneficial proteins in milk.
摘要:
The present invention provides a porcine beta-casein gene, a porcine beta-casein gene promoter, an expression vector comprising the same promoter, and a method for the production of a target protein using the same expression vector. The promoter of the present invention facilitates mammary gland-specific expression of the target protein and therefore can be useful for high-concentration production of beneficial proteins in milk.
摘要:
Disclosed are a hand-tearable adhesive tape which is made of a sheet woven with warps and wefts, in which the warps have a smaller titer than the wefts, and is coated with a flame retardant to provide flame retardancy and is with an adhesive agent, and a method for manufacturing the same. Advantageously, the hand-tearable adhesive tape can exhibit superior adhesive force, while providing flame retardancy and can be torn by hand.
摘要:
Disclosed are a hand-tearable adhesive tape which is made of a sheet woven with warps and wefts, in which the warps have a smaller titer than the wefts, and is coated with a flame retardant to provide flame retardancy and is with an adhesive agent, and a method for manufacturing the same. Advantageously, the hand-tearable adhesive tape can exhibit superior adhesive force, while providing flame retardancy and can be torn by hand.
摘要:
The present invention provides a mammary gland-specific human erythropoietin expression (hEPO) vector, transgenic animal and method for producing human erythropoietin using the same. The inventive hEPO-expressing transgenic animals express a mammary gland-specific EPO at an extremely higher concentration than the convention method. The hEPO produced from inventive transgenic animals shows better stability and superior physiological activity than those of the same kind of commerally available protein. Therefore, the inventive hEPO-expressing transgenic animals can be effectively used for production of EPO showing a superior physiological activity than the existing EPO.